Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Vaccine

• Publication date

  2000-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0264-410X(00)00180-8PMID 11027820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

  2000cited by this paper
• Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

  1999cited by this paper
• Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.

  1999cited by this paper
• Salivary antibodies following parenteral immunization of infants with a meningococcal serogroup A and C conjugated vaccine

  1999cited by this paper
• Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum.

  1998cited by this paper
• Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response.

  1998cited by this paper
• Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats.

  1998cited by this paper
• Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines

  1998cited by this paper
• IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.

  1998cited by this paper
• Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.

  1997cited by this paper
• Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.

  1996cited by this paper
• Carriage of pneumococci after pneumococcal vaccination.

  1996cited by this paper
• Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence *

  1996cited by this paper
• A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

  1995cited by this paper
• Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines.

  1995cited by this paper
• The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.

  1995cited by this paper
• Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type b polysaccharides in association with isolated outer membranes and in immunoassays

  1994cited by this paper
• Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats.

  1993cited by this paper
• Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization.

  1993cited by this paper
• Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay

  1992cited by this paper
• Humoral immunity in root caries in an elderly population. II..: Collection, processing, preservation of antibody activity and influence of diurnal and monthly variation on collection procedures

  1990cited by this paper
• Humoral immunity in root caries in an elderly population. 2.

  1990cited by this paper
• Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.

  1990cited by this paper
• Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine.

  1985cited by this paper
• Immunisation against bacterial meningitis.

  1981cited by this paper
• Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

  1981cited by this paper
• Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.

  1980cited by this paper
• Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

  1977cited by this paper
• Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.

  1977cited by this paper
• Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.

  1977cited by this paper
• Effect of group-A meningococcal vaccine in army recruits in Finland.

  1975cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper

• Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1

  2023cites this paper
• Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue

  2021cites this paper
• Scalable production and immunogenicity of a cholera conjugate vaccine

  2021cites this paper
• Herd Protection against Meningococcal Disease through Vaccination

  2020cites this paper
• Saliva: a reliable sample matrix in bioanalytics.

  2017cites this paper
• Greenwich Academic Literature Archive (GALA)

  2016cites this paper
• Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.

  2015cites this paper
• Mycobacterium tuberculosis Surface-binding Antibodies Influence Early Infection Events

  2015cites this paper
• Noninvasive Sampling of Saliva as an Alternative Way for Malaria Diagnosis: A Systematic Review

  2013cites this paper
• Infection with 2009 H1N1 Influenza Virus Primes for Immunological Memory in Human Nose-Associated Lymphoid Tissue, Offering Cross-Reactive Immunity to H1N1 and Avian H5N1 Viruses

  2013cites this paper
• Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination.

  2011cites this paper
• Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum

  2011cites this paper
• Serum Antibody Kinetics following Nasal or Parenteral Challenge with Meningococcal Polysaccharide in Healthy Adults

  2011cites this paper
• polysaccharide in healthy adults.

  2011cites this paper
• Development and characterization of the immune response induced by peptides and DNA constructs that mimic the capsular polysaccharide of Neisseria meningitidis serogroup C

  2005cites this paper
• Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

  2004cites this paper
• Neisseria meningitidis: an overview of the carriage state.

  2004cites this paper
• Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria

  2004cites this paper
• Neisseria meningitidis serogroup A vaccines: an overview

  2003cites this paper
• Effects of Sample Collection and Storage Methods on Antipneumococcal Immunoglobulin A in Saliva

  2003cites this paper
• Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide

  2003cites this paper
• Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants

  2002cites this paper
• Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.

  2002cites this paper
• Immune Responses to Novel Pneumococcal Proteins Pneumolysin, PspA, PsaA, and CbpA in Adenoidal B Cells from Children

  2002cites this paper
• Evaluation of diagnostic tests for influenza in a pediatric practice

  2002cites this paper
• Characterization of Humoral and Cellular Immune Responses Elicited by Meningococcal Carriage

  2002cites this paper
• Primary and Booster Mucosal Immune Responses to Meningococcal Group A and C Conjugate and Polysaccharide Vaccines Administered to University Students in the United Kingdom

  2001cites this paper
• Vaccine prevention of meningococcal disease, coming soon?

  2001cites this paper